Biodexa Pharmaceuticals (BDRX) Restructuring Costs (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) posted Restructuring Costs of -$3.2 million for Q2 2025, down 21.52% sequentially from -$2.6 million in Q4 2024.

Biodexa Pharmaceuticals (BDRX) Restructuring Costs (2013 - 2025) Analysis & Trends

Biodexa Pharmaceuticals has reported Restructuring Costs for 12 years, with the latest figure at -$3.2 million in Q2 2025.

Quarterly Restructuring Costs changed N/A year-over-year to -$3.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$10.8 million (changed N/A YoY) and the FY2025 annual result came in at -$6.4 million, down 30.98% from the prior year.
Restructuring Costs eased to -$3.2 million in Q2 2025 per BDRX's latest filing, from -$2.6 million in the prior quarter.
Over five years, Restructuring Costs peaked at -$2.2 million in Q4 2022 and troughed at -$3.2 million in Q2 2025.
A 5-year average of -$2.5 million and a median of -$2.3 million in 2022 frame the typical range for Restructuring Costs.
The sharpest annual moves came in 2021 and 2022: Restructuring Costs soared 65.86% in 2021, then retreated 0.59% in 2022.
Over 5 years, Restructuring Costs stood at -$2.2 million in 2021, then gained by 2.85% to -$2.2 million in 2022, then sank by 32.19% to -$2.9 million in 2023, then grew by 8.94% to -$2.6 million in 2024, then declined by 21.52% to -$3.2 million in 2025.
According to Business Quant data, Restructuring Costs over the past three periods registered -$3.2 million, -$2.6 million, and -$2.9 million for Q2 2025, Q4 2024, and Q2 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.41 Bn	130.56 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.12 Bn	78.12 Bn	3.93 Bn
3	Argenx Se	64.41 Bn	59.23 Bn	1.37 Bn
4	Moderna	57.56 Bn	52.43 Bn	52.00 Mn
5	BeOne Medicines	42.06 Bn	36.96 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.95 Bn	27.65 Bn	992.69 Mn
7	BioNTech SE	27.48 Bn	9.09 Bn	668.28 Mn
8	Insmed	27.31 Bn	26.15 Bn	358.27 Mn
9	Royalty Pharma	27.04 Bn	26.20 Bn	-
10	Biodexa Pharmaceuticals	65,947.56	-11.29 Mn	-

Download Data